Uncover key drivers, emerging technologies, and competitive movements shaping the manual tray sealers market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Zoonotic Disease Treatment Market reach by 2030 starting from 2026 levels?

The zoonotic disease treatment market size has experienced significant growth in recent years. It is projected to expand from $42.51 billion in 2025 to $45.48 billion in 2026, at a compound annual growth rate (CAGR) of 7.0%. This historical expansion can be attributed to frequent instances of zoonotic disease transmission, restricted disease surveillance in animal populations, a high dependency on conventional antibiotics, a deficiency in coordinated animal and human health strategies, and increased interaction between humans and animals.

The market for treating zoonotic diseases is anticipated to experience substantial expansion in the coming years. It is projected to reach $57.77 billion by 2030, showing a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period is attributable to progress in zoonotic disease diagnostics and therapeutics, increasing adoption of ‘One Health’ approaches, enhanced government funding for zoonotic disease control, expanding vaccination coverage in animals, and the broadening of global disease surveillance programs. Notable trends expected in the forecast period encompass a rising frequency of zoonotic disease outbreaks, a greater focus on preventive treatment and prophylaxis, increasing demand for broad-spectrum anti-infective therapies, the expansion of integrated animal and human health initiatives, and an emphasis on early diagnosis and rapid treatment commencement.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp

Which Drivers Are Influencing Long-Term Growth In The Zoonotic Disease Treatment Market?

A surge in the need for animal proteins is anticipated to fuel the expansion of the zoonotic disease treatment market in the foreseeable future. These proteins, obtained from animal sources like meat, dairy products, eggs, and fish, provide all vital amino acids crucial for human well-being. This heightened demand stems from an expanding worldwide population, increased disposable incomes, growing urbanization, and a greater understanding of the dietary advantages offered by foods derived from animals. Zoonotic disease treatments provide critical understanding for handling illnesses originating from animal proteins, identifying how they spread, creating potent treatments, and putting in place preventative strategies to lessen dangers to public health. As an illustration, the Australian Bureau of Statistics (ABS), Australia’s official national statistical agency, reported in March 2025 that the per capita consumption of meat and poultry products rose by 2.3% compared to 2023-24. This data indicates a noticeable increase in the intake of animal-based protein by weight within the national diet. Consequently, the escalating demand for animal proteins is a key factor propelling the growth of the zoonotic disease treatment market.

How Is The Zoonotic Disease Treatment Market Divided Into Segments?

The zoonotic disease treatment market covered in this report is segmented –

1) By Disease Type: Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types

2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes

3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents

4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations

5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

Subsegments:

1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)

2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment

3) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis

4) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment

5) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

What Industry Trends Are Transforming The Zoonotic Disease Treatment Market?

Leading companies within the zoonotic disease treatment market are concentrating their investments on strengthening diagnostic capabilities and refining treatment protocols for zoonotic diseases. This strategy includes developing advanced diagnostic technologies, such as PCR kits, to allow for faster identification of zoonotic pathogens and implementing targeted therapeutic interventions. For instance, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, announced the addition of thirteen new components to its Zoonotic Infectious Diseases Total PCR Solution. This enhancement aims to bolster its ability to diagnose zoonotic diseases, which comprise over 60% of all known infectious diseases and 75% of emerging infections. The initiative is intended to improve health security preparedness and response, especially as climate change contributes to the spread of infectious diseases into new geographic areas. With these new offerings, the company seeks to enable more rapid diagnoses and improved management of zoonotic infections, emphasizing the critical role of proactive public health measures.

Which Key Market Players Are Investing In Expansion And Innovation Within The Zoonotic Disease Treatment Market?

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Santé Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report

Which Regions Are Poised For Strategic Growth In The Zoonotic Disease Treatment Market?

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Zoonotic Disease Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15965&type=smp

Browse Through More Reports Similar to the Global Zoonotic Disease Treatment Market 2026, By The Business Research Company

Monkey Pox Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Animal Therapeutics And Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-therapeutics-and-diagnostics-global-market-report

Animal Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/animal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company